A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response. - Su,C.G.; Wen,X.; Bailey,S.T.; Jiang,W.; Rangwala,S.M.; Keilbaugh,S.A.; Flanigan,A.; Murthy,S.; Lazar,M.A.; Wu,G.D. (J Clin Invest, 1999)